Dianthus Therapeutics, Inc. /DE/ Quarterly Liabilities and Equity in USD from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Liabilities and Equity history and growth rate from Q4 2017 to Q2 2024.
  • Dianthus Therapeutics, Inc. /DE/ Liabilities and Equity for the quarter ending June 30, 2024 was $369M, a 369% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $369M +$290M +369% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $382M +$299M +358% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $179M +$96.3M +116% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $192M +$28.3M +17.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $78.6M -$96.5M -55.1% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $83.4M -$111M -57.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $83.1M +$73.7M +779% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $164M -$42.1M -20.4% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $175M -$45.3M -20.5% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $194M +$49.8M +34.4% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $9.45M -$152M -94.2% Dec 31, 2021 8-K 2023-12-21
Q3 2021 $206M +$31.6M +18.1% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $220M +$29.7M +15.5% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $145M +$179K +0.12% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $162M +$105K +0.07% Dec 31, 2020 10-K 2022-03-08
Q3 2020 $175M -$2.59M -1.46% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $191M -$4.71M -2.41% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $144M -$3.25M -2.2% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $162M +$4.2M +2.67% Dec 31, 2019 10-K 2021-03-03
Q3 2019 $177M +$4.44M +2.57% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $195M +$14.8M +8.21% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $148M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $157M +$103M +189% Dec 31, 2018 10-K 2020-03-03
Q3 2018 $173M Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $181M Jun 30, 2018 10-Q 2018-08-09
Q4 2017 $54.5M Dec 31, 2017 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.